Notably, Nakamura et al. [23] found PCT to be significantly more accurate than presepsin in patients with severe acute kidney injury, while Juneja et al. [22] reported similar efficacy between the two biomarkers but limited predictive value for ICU mortality. This evidence concerns the gene CALCA and acute kidney injury.